Babson Diagnostics, a, healthcare technology company, and BD (Becton, Dickinson, and Company), announced the expansion of a strategic partnership to move blood sample collection into new care settings, including enabling patients to collect blood samples at home for diagnostic testing, according to a news release.
Since 2019, the two companies have collaborated to create a capillary blood collection and testing system, now in advanced development, to enable laboratory-quality, small-volume capillary blood collection at retail settings by team members with no previous experience in blood collection. Plans under the expanded agreement include continuing research and development to enable self-collection, mobile services, and at-home collection. Babson and BD also will expand the types of blood tests that are possible through small-volume blood collection beyond primary care-oriented tests, and they also plan to develop diagnostic tests for pediatric use.
Over this long-term collaboration, Babson and BD are advancing development of the blood testing ecosystem, which includes BD's next generation capillary collection technology and Babson's proprietary automated sample-handling and analytical technologies. These have been designed to work together to enable blood testing that requires only one-tenth the sample volume of traditional venipuncture methods without sacrificing quality, accuracy, or the number and types of tests that are possible.
